The STEP 1 trial showed weight continued declining until approximately week 60
Dehydration and insulinopenia are necessary and sufficient for euglycemic ketoacidosis in SGLT2 inhibitor-treated rats
However, due to the heterogeneity of the study design (clinimetric parameters used as outcomes, the number of sessions, treatment intervals, and duration of follow-up), the diversity of device settings, and melasma characteristics, comparing these results is complicated [120]
SW, JW, DG, TM, PT, and SC contributed to data collection and data processing
Treatment Options Addressing Underlying Causes Treating low iron with supplements or infusions Adjusting or switching medications Managing chronic illnesses like kidney disease or diabetes Medications (if needed) Dopamine agonists (e.g., pramipexole, ropinirole) Anti-seizure drugs (e.g., gabapentin or pregabalin) Sleep aids or muscle relaxers in select cases We only prescribe meds when necessary and start with the lowest effective dose
Kinetic study of chondroitin sulphate release from chondroitin sulphate/chitosan complex hydrogel
